Strata Critical Medical, Inc. (SRTA) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Strata Critical Medical, Inc. stock $4.91, price $5.42, that is 9.4% below the price, quality 46 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Strata Critical Medical, Inc.
SRTA · USExpensive (fair value 9% below the price), weak company and price moving sideways: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 11, 2026.
How to read this chart
60‑month range $2.08 – $11.63 · fair‑value band $3.68 – $6.14 · the $5.42 price screens above the $4.91 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 11, 2026.
Every Wednesday you see whether Strata Critical Medical is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical.
Show moreShow less
The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services.
It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals.
The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
Stock analysis
Strata Critical Medical, Inc. (SRTA) currently trades at $5.42, while our estimate is $4.91, 9% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: $3.68 (bear) to $6.14 (bull), the price of $5.42 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 46/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Strata Critical Medical, Inc. reported revenue of $197M in FY2025 versus $50.5M in FY2021, a compound +40.5%/yr. Reported net income was −$15.6M in FY2025.
Key figures
Market cap $487M Small · P/S ratio 1.92 · EPS (TTM) $−0.2400 · Net margin −8.8% · Return on equity −7.6% · Return on assets (EBIT) −12.6% (5-year average) · Operating margin −4.3% · Revenue (TTM) $281M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (medium confidence).
What moves the price
The share trades about 16% below its 52-week high and 34% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −4% fair-value upside, at −9%, SRTA screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Insider trades
In the last 6 months, one officer or director bought shares worth $9,998, on Nov 5, 2026. Over the same period, 5 people sold shares worth $749,036.
- BuyAndrew LauckDirector2× since Dec 5, 2025: 7,000 shares, avg. $4.55$31,848Nov 5, 2026
- SaleReginald LoveDirector3× since Nov 19, 2025: 27,091 shares, avg. $4.60$124,753Aug 10, 2026
- SaleScott M WunschCEO, Logistics5,550 shares at $5.87$32,579Jun 8, 2026
- SaleMelissa M. TomkielCo-CEO and General Counsel, Director29,730 shares at $5.87$174,515Jun 8, 2026
- SaleAmir CohenChief Accounting Officer3× since May 11, 2026: 69,836 shares, avg. $5.87$409,592Jun 8, 2026
- SaleWilliam A. HeyburnCo-CEO and CFO, Director31,671 shares at $5.87$185,909Jun 8, 2026
- BuyWilliam A. HeyburnCo-CEO and CFO, Director17,000 shares at $4.47$75,990Dec 9, 2025
Plus 21 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Source: SEC Form 4, as of Nov 16, 2026. All filings at the SEC ↗
Revenue & earnings trend
SRTA screens overvalued: fair value 9% below the price. Compare with HCA Healthcare, Inc →
Earlier news
- Strata Critical Medical and 3 More Stocks See Action From Activist Investors
- Strata Critical Medical gains as activist Third Point takes stake, pushes for sale
- Strata Critical Medical (SRTA) Q2 2026 Earnings Call Transcript
- Immersion Investment Views Strata Critical Medical (SRTA) as a “Babushka Doll”
Compare Strata Critical Medical, Inc. with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 248 stocks
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Industrials sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- PEG ratio by industry
- Revenue growth by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Industrials
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Fresenius Medical Care AG FMS | $21.86 | $45.73 | +109% | vs SRTA |
| DaVita Inc DVA | $174.22 | $218.90 | +26% | vs SRTA |
| Aier Eye Hospital Group 300015 | ¥8.99 | ¥10.88 | +21% | vs SRTA |
| HCA Healthcare, Inc HCA | $511.78 | $547.34 | +7% | vs SRTA |
| Tenet Healthcare Corporation THC | $291.54 | $279.20 | −4% | vs SRTA |
| The Ensign Group ENSG | $188.23 | $140.09 | −26% | vs SRTA |
| Encompass Health Corporation EHC | $142.11 | $94.81 | −33% | vs SRTA |
| Fresenius SE FRE | €53.86 | €34.77 | −35% | vs SRTA |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,771 | ₹5,234 | −40% | vs SRTA |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 211.40 SAR | 109.45 SAR | −48% | vs SRTA |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Strata Critical Medical, Inc. (SRTA) overvalued or undervalued?
What is the fair value of SRTA?
What is the quality score of SRTA?
What is the price target for Strata Critical Medical, Inc. (SRTA)?
What is the Strata Critical Medical, Inc. stock forecast for 2026?
What is the revenue of Strata Critical Medical, Inc. (SRTA)?
What is the intrinsic value of Strata Critical Medical, Inc. (SRTA)?
Is Strata Critical Medical, Inc. stock overvalued or undervalued in 2026?
Is fair value the same as the market price of SRTA?
How much is Strata Critical Medical, Inc. worth?
What do the bullish and bearish scenarios say about SRTA?
How solid is the balance sheet of Strata Critical Medical, Inc. (SRTA)?
How far is SRTA from its 52-week high?
Which stocks are comparable to Strata Critical Medical, Inc.?
Is Strata Critical Medical, Inc. stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Strata Critical Medical, Inc. (SRTA)?
What should I pay attention to with Strata Critical Medical, Inc. right now?
Key figures of Strata Critical Medical, Inc.
How large is the market capitalisation of Strata Critical Medical, Inc. (SRTA)?
What is the P/S ratio of Strata Critical Medical, Inc. (SRTA)?
What are the earnings per share of Strata Critical Medical, Inc. (SRTA)?
What is the net margin of Strata Critical Medical, Inc. (SRTA)?
What is the return on equity of Strata Critical Medical, Inc. (SRTA)?
What is the EBIT return on assets of Strata Critical Medical, Inc. (SRTA)?
What is the operating margin of Strata Critical Medical, Inc. (SRTA)?
How fast is revenue growing at Strata Critical Medical, Inc. (SRTA)?
How much free cash flow does Strata Critical Medical, Inc. (SRTA) generate?
How much net cash does Strata Critical Medical, Inc. (SRTA) hold?
Watch Strata Critical Medical, Inc. in the live analysis
One click puts Strata Critical Medical, Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.